Fluticasone Nasal Spray Patient Preference Study
Information source: GlaxoSmithKline
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Allergic Rhinitis
Intervention: fluticasone propionate (Drug); fluticasone furoate (Drug)
Phase: Phase 3
Status: Completed
Sponsored by: GlaxoSmithKline Official(s) and/or principal investigator(s):
GSK Clinical Trials, M.D., Study Director, Affiliation: GlaxoSmithKline
Summary
The objectives of this study are to evaluate and compare patient preference for FF
(Fluticasone Furoate) and FP (Fluticasone Propionate Aqueous)nasal sprays in the treatment of
allergic rhinitis following single-dose administration.
Clinical Details
Official title: A Patient Preference Evaluation Study of Fluticasone Furoate Nasal Spray and Fluticasone Propionate Aqueous Nasal Spray in Subject With Allergic Rhinitis
Study design: Treatment, Randomized, Double-Blind, Active Control, Crossover Assignment
Primary outcome: overall subject preference for nasal spray
Secondary outcome: subject preference for individual attributes
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- allergic rhinitis
- literate
Exclusion Criteria:
- clinical significant uncontrolled disease
- Use of intranasal corticosteroids (<4 weeks of FP [branded or generic],<4 week
exposure to FF, <4 weeks use of other INS)
- Use of intranasal medications <1 week
- Use of meds that significantly inhibit CYP4503A4
- Use of perfume or oral rinse on study day
- Allergy/intolerance to INS, antihistamines, or excipients
- Positive pregnancy test or female who is breastfeeding
- Affiliation with investigational site
Locations and Contacts
GSK Clinical Trials Call Center, Fountain Valley, California 92708, United States
GSK Clinical Trials Call Center, San Diego, California 92123, United States
GSK Clinical Trials Call Center, Long Beach, California 90807, United States
GSK Clinical Trials Call Center, Lakewood, Colorado 80401, United States
GSK Clinical Trials Call Center, Denver, Colorado 80230, United States
GSK Clinical Trials Call Center, Savannah, Georgia 31406, United States
GSK Clinical Trials Call Center, Conyers, Georgia 30013, United States
GSK Clinical Trials Call Center, Ypsilanti, Michigan 48197, United States
GSK Clinical Trials Call Center, Minneapolis, Minnesota 55402, United States
GSK Clinical Trials Call Center, St. Louis, Missouri 63141, United States
GSK Clinical Trials Call Center, Rolla, Missouri 65401, United States
GSK Clinical Trials Call Center, Skillman, New Jersey 08558, United States
GSK Clinical Trials Call Center, Brick, New Jersey 08724, United States
GSK Clinical Trials Call Center, Charleston, South Carolina 29414, United States
GSK Clinical Trials Call Center, El Paso, Texas 79925, United States
Additional Information
Starting date: December 2006
Last updated: April 8, 2008
|
